CancerNCT06439316
Physical Function and Mental Health in Cancer Survivors
An observational study of Cancer and Sedentary Behavior, run by West China Hospital.
Trial summary
The goal of this observational study is to evaluate the joint prognostic effects of physical function and mental health on survival of cancer survivors. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer, Sedentary Behavior, Depressive Symptoms
- What is being tested?
- Sedentary behavior and Depressive symptoms
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 2,932 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2007to 31 Dec 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Cancer survivors were selected from the National Health and Nutrition Examination Survey (NHANES) program between 2007 and 2018.
Who may be able to join
- Adults with aged above 18 year old
Who cannot join
- Without a history of cancers
- Without records of sedentary behavior or depressive symptoms test
- Incomplete follow-up information
About this study
Official title: Joint Association Between Sedentary Behavior and Depressive Symptoms With Mortality Outcomes Among Cancer Survivors
The goal of this observational study is to evaluate the joint prognostic effects of physical function and mental health on survival of cancer survivors.
Read the detailed description
Cancer survivors were selected from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2018. Total sedentary time was assessed by self-reported daily hours of sitting and depressive symptoms were assessed by Patient Health Questionnaire 9 (PHQ-9). Kaplan-Meier (KM) curves and the Cox regression analyses were used to evaluate the separate and joint prognostic effects of sedentary behavior and depressive symptoms with mortality outcomes of cancer survivors.
- Conditions
- Cancer, Sedentary Behavior, Depressive Symptoms, Survivorship
- Being tested
- Sedentary behavior, Depressive symptoms
- Medical subject headings
- Neoplasms, Sedentary Behavior, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sedentary behaviorBehavioural
Total sedentary time was assessed by self-reported daily hours of sitting
Depressive symptomsBehavioural
depressive symptoms were assessed by Patient Health Questionnaire 9 scale
What is being measured
The primary outcome is the main question the study is designed to answer.
All-cause mortality of cancer survivors
Joint association between sedentary behavior and depressive symptoms with all-cause mortality of cancer survivors
Measured: Jan 1, 2007 to 31 Dec, 2019
Cancer mortality of cancer survivors
Joint association between sedentary behavior and depressive symptoms with cancer mortality of cancer survivors
Measured: Jan 1, 2007 to 31 Dec, 2019
Non-cancer mortality of cancer survivors
Joint association between sedentary behavior and depressive symptoms with non-cancer mortality of cancer survivors
Measured: Jan 1, 2007 to 31 Dec, 2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2024
- Study start1 Jan 2007
- Primary completion31 Dec 2018
- Study completion31 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by West China HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 2,932 participants (actual)
Sponsor and investigators
- Lead sponsor
- West China Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lei Liu, West China Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06439316
- Sponsor's protocol ID
- #2011-18
- Status last verified
- May 2024
- First submitted
- 28 May 2024
- Last updated
- 3 Jun 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Joint Association Between Sedentary Behavior and Depressive Symptoms With Mortality Outcomes Among Cancer Survivors
- ClinicalTrials.gov ID
- NCT06439316
- Acronym / sponsor ID
- #2011-18
- Conditions
- Cancer, Sedentary Behavior, Depressive Symptoms, Survivorship
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,932 participants (actual)
- Lead sponsor
- West China HospitalUniversity, hospital or other
- Study start
- 1 Jan 2007 (actual)
- Primary completion
- 31 Dec 2018 (actual)
- Study completion
- 31 Dec 2018 (actual)
- First posted
- 3 Jun 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to evaluate the joint prognostic effects of physical function and mental health on survival of cancer survivors.
Detailed description
Cancer survivors were selected from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2018. Total sedentary time was assessed by self-reported daily hours of sitting and depressive symptoms were assessed by Patient Health Questionnaire 9 (PHQ-9). Kaplan-Meier (KM) curves and the Cox regression analyses were used to evaluate the separate and joint prognostic effects of sedentary behavior and depressive symptoms with mortality outcomes of cancer survivors.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Cancer survivors were selected from the National Health and Nutrition Examination Survey (NHANES) program between 2007 and 2018.
Key inclusion criteria (1 listed)
- Adults with aged above 18 year old
Key exclusion criteria (3 listed)
- Without a history of cancers
- Without records of sedentary behavior or depressive symptoms test
- Incomplete follow-up information
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sedentary behaviorTotal sedentary time was assessed by self-reported daily hours of sitting | Behavioural | – |
| Depressive symptomsdepressive symptoms were assessed by Patient Health Questionnaire 9 scale | Behavioural | – |
Primary outcome
All-cause mortality of cancer survivors
Time frame: Jan 1, 2007 to 31 Dec, 2019
Joint association between sedentary behavior and depressive symptoms with all-cause mortality of cancer survivors
Cancer mortality of cancer survivors
Time frame: Jan 1, 2007 to 31 Dec, 2019
Joint association between sedentary behavior and depressive symptoms with cancer mortality of cancer survivors
Non-cancer mortality of cancer survivors
Time frame: Jan 1, 2007 to 31 Dec, 2019
Joint association between sedentary behavior and depressive symptoms with non-cancer mortality of cancer survivors
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2024.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer and Sedentary Behavior, run by West China Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
All-cause mortality of cancer survivors (time frame: Jan 1, 2007 to 31 Dec, 2019). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2024.